SDLPharmaceuticals
Southern Palladium Ltd — Quarterly Results & Earnings
₹34.93
+0.00%
Profit Growth YoY-200.00%Latest quarter
Sales Growth YoY173.21%Latest quarter
Sales CAGR 5Y-0.91%5 year compound
Profit CAGR 5Y12.99%5 year compound
📋
Quarterly Performance
YoY Profit Growth-200.00%
🔴 Significant decline
YoY Sales Growth+173.21%
🔥 Exceptional growth
OPM 5Y Average
0.04%Operating profit margin
EPS Growth 5Y
12.99%Interest Coverage
-2.21Higher = safer debt servicing
ROE
N/AROCE
-186.79%💡
Growth Analysis
Southern Palladium Ltd reported YoY profit growth of -200.00% and revenue growth of 173.21% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -0.91% and profits at 12.99% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Southern Palladium Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.